Consensus Aier Eye Hospital Group Co., Ltd.
Equities
300015
CNE100000GR6
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.30 CNY | +0.62% |
|
-0.88% | -14.72% |
| 11-28 | Aier Eye Hospital Group Co., Ltd. Approves Interim Dividend of Year 2025 | CI |
| 11-28 | Aier Eye Hospital Group Co., Ltd. Appoints Liu Duan and Tian Suhua as Independent Director | CI |
Evolution of the Average Target: Aier Eye Hospital Group Co., Ltd.
Evolution of the Target Price: Aier Eye Hospital Group Co., Ltd.
Changes in Analyst Recommendations: Aier Eye Hospital Group Co., Ltd.
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
| +26.07% | ||||||
| +6.57% | ||||||
| +20.72% | ||||||
| +24.17% | ||||||
| +16.44% | ||||||
| +53.35% | ||||||
| +52.67% | ||||||
| +18.65% | ||||||
| +1.9% | ||||||
| +5.42% | ||||||
| Average | +22.60% | |||||
| Weighted average by Cap. | +22.67% |
Analysts' Consensus

Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| Nomura | |
| UOB Kay Hian | |
| JPMorgan | |
| Citigroup | |
| Goldman Sachs | |
| UBS |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300015 Stock
- Consensus Aier Eye Hospital Group Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















